Page last updated: 2024-08-18

pyrroles and Autoimmune Diabetes

pyrroles has been researched along with Autoimmune Diabetes in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (2.38)	18.7374
1990's	5 (11.90)	18.2507
2000's	19 (45.24)	29.6817
2010's	16 (38.10)	24.3611
2020's	1 (2.38)	2.80

Authors

Authors	Studies
Goto, M; Hori, M; Iio, A; Kaji, N; Kishi, K; Nonoshita, Y; Tsuru, Y; Yonezawa, T	1
Adamson, U; Jörneskog, G; Lins, PE; Mobarrez, F; Tehrani, S; Wallén, HN	1
Arch, RH; Atkinson, MA; Bluestone, JA; Brekken, RA; Calderon, B; Kabre, B; Kubeck, S; Lang, J; Pullen, N; Szot, GL; Villalta, SA; Wasserfall, C	1
Brudi, P; Hanson, ME; Jimenez, JG; Massaad, R; Pirags, V; Rosen, JB; Triscari, J; Vides, H	1
Anver, MR; Awasthi, P; Bamford, R; Butcher, DO; Chen, J; Discepolo, V; Feigenbaum, L; Golubeva, YG; Jabri, B; St Claire, MB; Thomas, CJ; Waldmann, TA; Zhang, X	1
Casiano, H; Crespo, MJ; Cruz, N; Hernandez, C; Quidgley, J; Rivera, K; Torres, H	1
Bao, W; Betteridge, DJ; Buchan, AP; Colhoun, H; DeMicco, DA; Durrington, PN; Fuller, JH; Hawa, MI; Hitman, GA; Leslie, RD; Neil, HA; Ola, T; Wun, CC	1
Amiel, SA; Aylwin, SJ; Huda, MS; Ross, P	1
Doerfer, J; Grulich-Henn, J; Grünert, SC; Holder, M; Krebs, A; Lichte, K; Schmidt-Trucksäss, A; Schwab, KO; Stier, B; Winkler, K; Wöhrl, J	1
Canas, JA; Caulfield, MP; Damaso, LC; Gidding, SS; Hossain, J; Mauras, N; Ross, JL; Sikes, KM; Taboada, MV	1
Bluestone, JA; Bollag, G; Lang, J; Lee, MR; Louvet, C; Martinier, N; Szot, GL; Weiss, A; Zhu, S	1
Bantly, A; Hamamdzic, D; Mohler, ER; Moore, J; Parmacek, M; Putt, M; Rader, DJ; Shi, Y; Wilensky, RL; Yoder, M; Zhang, L	1
Haller, MJ; Pepine, C; Samyn, MM; Shuster, JJ; Silverstein, JH; Stein, JM; Theriaque, D	1
Adamson, U; Antovic, A; Henriksson, P; Jörneskog, G; Lins, PE; Mobarrez, F; Santesson, P; Tehrani, S; Wallén, NH	1
Heinemann, L; Heise, T; Herder, C; Koenig, W; Kolb, H; Martin, S; Schloot, NC	1
Eeg-Olofsson, K; Eliasson, B; Gudbjörnsdóttir, S; Jonasson, JM; Miftaraj, M; Sundell, KA; Svensson, AM	1
Berruti, A; Pia, A; Terzolo, M	1
Huang, YJ; Li, Y; Wang, S	1
Heinemann, L; Heise, T; Herder, C; Koenig, W; Kolb, H; Martin, S; Roden, M; Schloot, NC; Simon, MC; Strom, A	1
Brudi, P; Hanson, ME; Jimenez, JG; Massaad, R; Pirags, V; Rosen, JB; Triscari, J	1
Beppu, M; Hata, I; Hiraoka, M; Kaji, M; Kawakami, H; Mayumi, M; Momoi, T; Sekine, K; Todoroki, Y; Tsukahara, H; Uchiyama, M; Yorifuji, T; Yoshihara, K	1
Barshes, NR; Goodpastor, SE; Goss, JA	1
Caselli, A; Economides, PA; Horton, ES; Khaodhiar, L; Tiani, E; Veves, A	1
De Leeuw, I; Manuel-Y-Keenoy, B; Van Gaal, L; Vertommen, J; Vinckx, M	1
Chan, DC; Dogra, GK; Stanton, K; Watts, GF	1
Blanco-Vaca, F; Calpe-Berdiel, L; Carrillo, J; Mauricio, D; Palomer, X; Pastor, X; Verdaguer, J	1
Bell, DS; Vaughan, TB	1
Brumeanu, TD; Casares, S; Goldstein, R	1
Barone, F; Lozanoska-Ochser, B; Peakman, M; Pitzalis, C	1
Kaupper, T; Walter, M; Ziegler, AG	1
Dhayat, N; Dhayat, S; Du, J; Hilfiker-Kleiner, D; Laufs, U; Noutsias, M; Riad, A; Schultheiss, HP; Spillmann, F; Tschöpe, C; Van Linthout, S; Westermann, D	1
Cieslik, G; Fedak, D; Galicka-Latala, D; Konduracka, E; Naskalski, J; Piwowarska, W; Rostoff, P; Sieradzki, J	1
Bauersachs, J; Brandt, M; Closs, E; Daiber, A; Ertl, G; Förstermann, U; Münzel, T; Oelze, M; Thum, T; Wenzel, P; Xu, J; Zou, MH	1
Brändle, M; Cerny, T; Gillessen, S; Templeton, A	1
Angel, I; Burcelin, R; Girard, J; Langer, SZ; Prouteau, M	1
Bellmunt, MJ; Bergua, M; Nagaraj, RH; Pamplona, R; Portero-Otín, M; Prat, J	1
Bellmunt, MJ; Bergua, M; Pamplona, R; Portero-Otín, M; Prat, J	1
Block, C; Ferguson, K; Fogarty, J; Haas, C; Hampel, N; Ni, Z; Polak, J; Razmjouei, K; Seftel, AD; Vaziri, ND; Wang, RZ	1
Gänzer, H; Kirchmair, R; Patsch, JR; Sturm, W	1
Deanfield, JE; Donald, AE; Mullen, MJ; Thomson, H; Thorne, S; Wright, D	1
Candiano, G; Delfino, G; Ghiggeri, GM; Queirolo, C	1

Reviews

3 review(s) available for pyrroles and Autoimmune Diabetes

Article	Year
Down-regulation of autoreactive T-cells by HMG CoA reductase inhibitors. Clinical immunology (Orlando, Fla.), 2006, Volume: 119, Issue:1 Topics: Animals; Antigen-Presenting Cells; Atorvastatin; Autoimmune Diseases; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Down-Regulation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; T-Lymphocytes	2006
[Immunointervention in newly diagnosed type 1 diabetes]. Deutsche medizinische Wochenschrift (1946), 2006, Dec-08, Volume: 131, Issue:49 Topics: Antibodies, Monoclonal; Atorvastatin; Autoimmune Diseases; Diabetes Mellitus, Type 1; Heptanoic Acids; Humans; Immunosuppressive Agents; Insulin-Secreting Cells; Prediabetic State; Pyrroles	2006
[Statins in diabetic hyperlipidemia]. Wiener medizinische Wochenschrift (1946), 1999, Volume: 149, Issue:5-6 Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Pyrroles; Risk Factors; Triglycerides	1999

Trials

15 trial(s) available for pyrroles and Autoimmune Diabetes

Article	Year
Impaired endothelium-dependent skin microvascular function during high-dose atorvastatin treatment in patients with type 1 diabetes. Diabetes & vascular disease research, 2013, Volume: 10, Issue:6 Topics: Administration, Cutaneous; Adult; Atorvastatin; Biomarkers; Cell-Derived Microparticles; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Double-Blind Method; Dyslipidemias; Endothelium, Vascular; Female; Glycated Hemoglobin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iontophoresis; Laser-Doppler Flowmetry; Male; Microcirculation; Middle Aged; Pyrroles; Risk Factors; Skin; Sweden; Time Factors; Treatment Outcome; Vasodilator Agents	2013
Consistency of effect of ezetimibe/simvastatin compared with intensified lipid-lowering treatment strategies in obese and non-obese diabetic subjects. Lipids in health and disease, 2013, Jul-16, Volume: 12 Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Apolipoproteins B; Atorvastatin; Azetidines; Cholesterol, LDL; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Ezetimibe; Female; Fluorobenzenes; Heptanoic Acids; Humans; Male; Middle Aged; Obesity; Peptide Fragments; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Treatment Outcome; Young Adult	2013
LADA and CARDS: a prospective study of clinical outcome in established adult-onset autoimmune diabetes. Diabetes care, 2014, Volume: 37, Issue:6 Topics: Adult; Age of Onset; Aged; Anticholesteremic Agents; Atorvastatin; Autoantibodies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Germany; Glucose Intolerance; Glutamate Decarboxylase; Heptanoic Acids; Humans; Hypoglycemic Agents; Insulin; Male; Metabolic Syndrome; Middle Aged; Phenotype; Prevalence; Prospective Studies; Pyrroles; Risk Factors	2014
Decreased levels of homoarginine and asymmetric dimethylarginine in children with type 1 diabetes: associations with cardiovascular risk factors but no effect by atorvastin. Journal of pediatric endocrinology & metabolism : JPEM, 2015, Volume: 28, Issue:1-2 Topics: Adolescent; Anticholesteremic Agents; Arginine; Atorvastatin; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glycated Hemoglobin; Heptanoic Acids; Homoarginine; Humans; Lipids; Male; Pilot Projects; Pyrroles; Risk Factors; Treatment Outcome	2015
A randomized, double blind, placebo-controlled pilot trial of the safety and efficacy of atorvastatin in children with elevated low-density lipoprotein cholesterol (LDL-C) and type 1 diabetes. Pediatric diabetes, 2015, Volume: 16, Issue:2 Topics: Adolescent; Atorvastatin; Child; Cholesterol, LDL; Combined Modality Therapy; Diabetes Mellitus, Type 1; Diet, Diabetic; Diet, Fat-Restricted; Double-Blind Method; Drug Monitoring; Exercise; Female; Glycated Hemoglobin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Pilot Projects; Pyrroles	2015
Pediatric Atorvastatin in Diabetes Trial (PADIT): a pilot study to determine the effect of atorvastatin on arterial stiffness and endothelial function in children with type 1 diabetes mellitus. Journal of pediatric endocrinology & metabolism : JPEM, 2009, Volume: 22, Issue:1 Topics: Adolescent; Adult; Anticholesteremic Agents; Atorvastatin; Child; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Double-Blind Method; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Male; Patient Compliance; Peripheral Vascular Diseases; Pilot Projects; Placebos; Pyrroles; Radial Artery; Vascular Resistance; Young Adult	2009
Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia. Thrombosis research, 2010, Volume: 126, Issue:3 Topics: Adult; Aged; Atorvastatin; Biomarkers; Blood Platelets; C-Reactive Protein; Cell-Derived Microparticles; Cross-Over Studies; Diabetes Mellitus, Type 1; Double-Blind Method; Dyslipidemias; Fibrin; Fibrinolytic Agents; Glycated Hemoglobin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Integrin beta3; Middle Aged; P-Selectin; Plasminogen Activator Inhibitor 1; Pyrroles; Sweden; Thrombin; Thromboplastin; Thrombosis; Time Factors; Treatment Outcome	2010
Residual beta cell function in newly diagnosed type 1 diabetes after treatment with atorvastatin: the Randomized DIATOR Trial. PloS one, 2011, Mar-11, Volume: 6, Issue:3 Topics: Adult; Atorvastatin; C-Peptide; Diabetes Mellitus, Type 1; Female; Glycated Hemoglobin; Heptanoic Acids; Humans; Insulin-Secreting Cells; Lipids; Male; Pyrroles; Treatment Outcome	2011
Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial). PloS one, 2012, Volume: 7, Issue:3 Topics: Adolescent; Adult; Age of Onset; Atorvastatin; C-Peptide; C-Reactive Protein; Diabetes Mellitus, Type 1; Female; Germany; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin-Secreting Cells; Male; Pyrroles; Young Adult	2012
The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome. Diabetes, obesity & metabolism, 2013, Volume: 15, Issue:6 Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Apolipoproteins B; Atorvastatin; Azetidines; Blood Glucose; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ezetimibe, Simvastatin Drug Combination; Fasting; Female; Fluorobenzenes; Heptanoic Acids; Humans; Male; Metabolic Syndrome; Middle Aged; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Treatment Outcome	2013
The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes. The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:2 Topics: Adult; Atorvastatin; Biomarkers; Brachial Artery; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Female; Forearm; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Microcirculation; Middle Aged; Nitroglycerin; Pyrroles; Regional Blood Flow; Risk Factors; Skin; Vasodilation; Vasodilator Agents	2004
Impact of Vitamin E supplementation on lipoprotein peroxidation and composition in Type 1 diabetic patients treated with Atorvastatin. Atherosclerosis, 2004, Volume: 175, Issue:2 Topics: Adult; Aged; alpha-Tocopherol; Antioxidants; Atorvastatin; Diabetes Mellitus, Type 1; Dietary Supplements; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Peroxidation; Lipoproteins; Male; Middle Aged; Pyrroles	2004
Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria. Diabetic medicine : a journal of the British Diabetic Association, 2005, Volume: 22, Issue:3 Topics: Adolescent; Adult; Aged; Albuminuria; Apolipoproteins B; Atorvastatin; Brachial Artery; Cholesterol, LDL; Cross-Over Studies; Cyclic GMP; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Linear Models; Lipoproteins, LDL; Male; Middle Aged; Nitroglycerin; Pyrroles; Regional Blood Flow; Statistics, Nonparametric; Vasodilation; Vasodilator Agents	2005
Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension. Diabetes, obesity & metabolism, 2008, Volume: 10, Issue:9 Topics: Adult; Atorvastatin; Brachial Artery; Coronary Artery Disease; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Pyrroles; Vasodilation; von Willebrand Factor	2008
Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: a double-blind study. Journal of the American College of Cardiology, 2000, Volume: 36, Issue:2 Topics: Adolescent; Adult; Arginine; Atorvastatin; Diabetes Mellitus, Type 1; Double-Blind Method; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Vasodilation	2000

Other Studies

24 other study(ies) available for pyrroles and Autoimmune Diabetes

Article	Year
Toceranib phosphate (Palladia) reverses type 1 diabetes by preserving islet function in mice. The Journal of veterinary medical science, 2023, Jul-17, Volume: 85, Issue:7 Topics: Animals; Diabetes Mellitus, Type 1; Insulins; Mice; Protein Kinase Inhibitors; Pyrroles; Rodent Diseases; Streptozocin	2023
Inhibition of VEGFR-2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function. Diabetes, 2013, Volume: 62, Issue:8 Topics: Animals; Diabetes Mellitus, Type 1; Female; Humans; Hyperglycemia; Indoles; Inflammation; Islets of Langerhans; Mice; Mice, Inbred NOD; Pancreas; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Vascular Endothelial Growth Factor Receptor-2	2013
Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL-15Rα. Proceedings of the National Academy of Sciences of the United States of America, 2013, Aug-13, Volume: 110, Issue:33 Topics: Animals; Diabetes Mellitus, Type 1; Disease Models, Animal; Humans; Insulin-Secreting Cells; Interleukin-15; Interleukin-15 Receptor alpha Subunit; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Transgenic; Piperidines; Pyrimidines; Pyrroles; Signal Transduction	2013
Daily administration of atorvastatin and simvastatin for one week improves cardiac function in type 1 diabetic rats. Pharmacology, 2014, Volume: 93, Issue:1-2 Topics: Animals; Atorvastatin; Blood Glucose; Cardiac Output; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Administration Schedule; Heart; Heart Rate; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Pyrroles; Rats; Rats, Sprague-Dawley; Simvastatin; Ventricular Function, Left	2014
Tyrosine kinase inhibitor sunitinib allows insulin independence in long-standing type 1 diabetes. Diabetes care, 2014, Volume: 37, Issue:5 Topics: Antineoplastic Agents; Diabetes Mellitus, Type 1; Fatal Outcome; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Indoles; Insulin Aspart; Insulin Glargine; Insulin, Long-Acting; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Protein Kinase Inhibitors; Pyrroles; Sunitinib	2014
Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice. Proceedings of the National Academy of Sciences of the United States of America, 2008, Dec-02, Volume: 105, Issue:48 Topics: Animals; Antineoplastic Agents; Benzamides; Blood Glucose; Diabetes Mellitus, Type 1; Female; Humans; Imatinib Mesylate; Indoles; Leukocytes; Mice; Mice, Inbred NOD; Mice, SCID; Pancreas; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Receptor, Platelet-Derived Growth Factor beta; Remission Induction; Sunitinib	2008
Diabetes reduces bone marrow and circulating porcine endothelial progenitor cells, an effect ameliorated by atorvastatin and independent of cholesterol. Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2009, Volume: 75, Issue:1 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Antibiotics, Antineoplastic; Anticholesteremic Agents; Atorvastatin; Azetidines; Bone Marrow Cells; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Endothelial Cells; Ezetimibe; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Stem Cells; Swine; Vasodilation	2009
Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT). BMC pediatrics, 2009, Dec-17, Volume: 9 Topics: Adolescent; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Area Under Curve; Atorvastatin; Biomarkers; Cardiomyopathies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Multicenter Studies as Topic; Puberty; Pyrroles; Quinapril; Randomized Controlled Trials as Topic; Research Design; Risk; Tetrahydroisoquinolines	2009
Clinical use and effectiveness of lipid lowering therapies in diabetes mellitus--an observational study from the Swedish National Diabetes Register. PloS one, 2011, Apr-29, Volume: 6, Issue:4 Topics: Adolescent; Adult; Aged; Atorvastatin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Models, Statistical; Pyrimidines; Pyrroles; Registries; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Sweden; Treatment Outcome	2011
Advances in pancreatic neuroendocrine tumor treatment. The New England journal of medicine, 2011, 05-12, Volume: 364, Issue:19 Topics: Animals; Antineoplastic Agents; Diabetes Mellitus, Type 1; Glucagonoma; Humans; Indoles; Insulinoma; Mice; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Receptors, Platelet-Derived Growth Factor; Sunitinib	2011
[The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy]. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2011, Volume: 27, Issue:9 Topics: Albuminuria; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Expression Regulation; Indoles; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Podocytes; Protein Kinase Inhibitors; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Vascular Endothelial Growth Factor; RNA, Messenger; Vascular Endothelial Growth Factor A	2011
Formation of advanced glycosylation end products and oxidative stress in young patients with type 1 diabetes. Pediatric research, 2003, Volume: 54, Issue:3 Topics: 8-Hydroxy-2'-Deoxyguanosine; Acrolein; Adolescent; Adult; Arginine; Child; Child, Preschool; Creatinine; Deoxyguanosine; Diabetes Mellitus, Type 1; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Norleucine; Oxidative Stress; Pyrroles; Regression Analysis	2003
Sirolimus-atorvastatin drug interaction in the pancreatic islet transplant recipient. Transplantation, 2003, Dec-15, Volume: 76, Issue:11 Topics: Adult; Atorvastatin; Diabetes Mellitus, Type 1; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Islets of Langerhans Transplantation; Pyrroles; Sirolimus	2003
Atorvastatin does not decrease or delay diabetes onset in two different mouse models of type 1 diabetes. Diabetologia, 2005, Volume: 48, Issue:8 Topics: Animals; Atorvastatin; Blood Glucose; Diabetes Mellitus, Type 1; Female; Food-Drug Interactions; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Pyrroles	2005
Statin neuropathy masquerading as diabetic autoimmune polyneuropathy. Diabetes care, 2005, Volume: 28, Issue:8 Topics: Adolescent; Anticholesteremic Agents; Atorvastatin; Autoimmunity; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Heptanoic Acids; Humans; Pyrroles; Restless Legs Syndrome	2005
Atorvastatin fails to prevent the development of autoimmune diabetes despite inhibition of pathogenic beta-cell-specific CD8 T-cells. Diabetes, 2006, Volume: 55, Issue:4 Topics: Animals; Atorvastatin; CD8-Positive T-Lymphocytes; Diabetes Mellitus, Type 1; Female; Heptanoic Acids; Histocompatibility Antigens Class II; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interferon-gamma; Interleukin-10; Interleukin-4; Mice; Mice, Inbred NOD; Pyrroles	2006
Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy. Diabetologia, 2007, Volume: 50, Issue:9 Topics: Animals; Anti-Inflammatory Agents; Atorvastatin; Collagen; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Heart; Heptanoic Acids; Inflammation; Myocardium; Pyrroles; Rats; Rats, Sprague-Dawley; Ventricular Dysfunction, Left; Ventricular Function, Left	2007
Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. Atherosclerosis, 2008, Volume: 198, Issue:1 Topics: Animals; Atorvastatin; Biopterins; Body Weight; Cell Adhesion Molecules; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Disease Models, Animal; Endothelium, Vascular; Enzyme Activation; GTP Cyclohydrolase; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intramolecular Oxidoreductases; Male; Microfilament Proteins; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphoproteins; Pyrroles; Rats; Rats, Wistar; Stem Cells; Tetrahydrofolate Dehydrogenase; Vasodilation	2008
Remission of diabetes while on sunitinib treatment for renal cell carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:4 Topics: Antineoplastic Agents; Blood Glucose; Carcinoma, Renal Cell; Dendritic Cells; Diabetes Complications; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Indoles; Insulin; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Sunitinib; Treatment Outcome	2008
Normalization of insulin secretion by a selective alpha 2-adrenoceptor antagonist restores GLUT-4 glucose transporter expression in adipose tissue of type II diabetic rats. Endocrinology, 1996, Volume: 137, Issue:5 Topics: Adipose Tissue; Adipose Tissue, Brown; Adrenergic alpha-Antagonists; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Gene Expression; Glucose Tolerance Test; Glucose Transporter Type 4; Indoles; Insulin; Insulin Secretion; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Myocardium; Pyrroles; Rats; Rats, Wistar; RNA, Messenger	1996
Urinary pyrraline as a biochemical marker of non-oxidative Maillard reactions in vivo. Life sciences, 1997, Volume: 60, Issue:4-5 Topics: Adolescent; Adult; Biomarkers; Chromatography, High Pressure Liquid; Creatinine; Diabetes Mellitus, Type 1; Female; Humans; Hydrolysis; Maillard Reaction; Male; Mass Spectrometry; Norleucine; Pyrroles; Reference Standards; Spectrophotometry, Ultraviolet	1997
Glycaemic control and in vivo non-oxidative Maillard reaction: urinary excretion of pyrraline in diabetes patients. European journal of clinical investigation, 1997, Volume: 27, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Child; Chromatography, High Pressure Liquid; Creatinine; Diabetes Mellitus, Type 1; Female; Fructosamine; Glycated Hemoglobin; Humans; Maillard Reaction; Male; Matched-Pair Analysis; Middle Aged; Norleucine; Pyrroles; Regression Analysis; Urea	1997
Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology, 1997, Volume: 50, Issue:6 Topics: Adult; Aged; Arginine; Blotting, Western; Chromatography, High Pressure Liquid; Cross-Linking Reagents; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Electron Probe Microanalysis; Endothelium; Enzyme Induction; Erectile Dysfunction; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lysine; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Norleucine; Penis; Pyrroles	1997
Reactivity with diazonium salts of albumin from micro and macroalbuminuric diabetic patients. Diabete & metabolisme, 1987, Volume: 13, Issue:1 Topics: Adult; Albuminuria; Diabetes Mellitus, Type 1; Diazonium Compounds; Female; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Pyrroles; Serum Albumin; Sulfanilic Acids	1987